Orion Nutraceuticals Voting Results of the Annual General and Special Meeting of Shareholders held on July 4, 2025
(TheNewswire)
Vancouver, British Columbia –TheNewswire - July 7, 2025 – Orion Nutraceuticals Inc., (CSE: ORI) (the “Company” or“Orion”) announces theresults of the Annual General and Special Meeting held on July 4, 2025(the “Meeting”).
The Company is pleased to announce that all matterssubmitted to shareholders for approval as set forth in the Company’sNotice of Meeting and Information Circular, both dated May 20, 2025,were approved at the Meeting. There were 16 shareholders representedin person or by proxy at the Meeting, holding 4,823,184 common shares,representing 16.46% of the Company’s total issued and outstandingcommon shares as of the record date for the Meeting. The votingresults for each matter presented at the Meeting are set outbelow.
Number of Directors
The resolution to set the number of directors of theCompany at three (3) was approved by the shareholders present orrepresented by proxy at the Meeting who voted on the resolution. Thevoting results are set out below:
Votes For | 4,784,636 | |
Votes Against | 99.20% | |
38,548 | ||
0.80% | ||
Election of Directors
Each of the nominees listed in the Company’sInformation Circular dated May 20, 2025, was elected as a director ofthe Company to hold office for the ensuing year, or until theirsuccessors are elected or appointed. The voting results are set outbelow:
Votes For | Votes Withheld | |||
# | % | # | % | |
Guy Bourgeois | 4,175,708 | 86.58% | 647,476 | 13.42% |
Amanda Boudreau | 4,200,498 | 87.09% | 622,686 | 12.91% |
Troy Grant | 4,175,748 | 86.58% | 647,436 | 13.42% |
Appointment of Auditors
Dale Matheson Carr-Hilton Labonte LLP was reappointedas auditor of the Company for the ensuing year, with remuneration tobe fixed by the board of directors. The voting results are set outbelow:
Votes For | 4,812,980 | |
Votes Against | 99.788% | |
10,204 | ||
0.212% | ||
Voluntary Delisting from the Canadian Securities Exchange
The Company sought disinterested shareholder approval
to voluntarily delist (the "Delisting") its common shares from the
Canadian Securities Exchange (the "CSE" or the
"Exchange"). The voting results are set out
below:
Votes For | 3,511,566 | |
Votes Against | 72.81% | |
1,311,618 | ||
27.19% | ||
While disinterested shareholder approval has been obtained for the Delisting,
the board of directors continues to review its position. No decision
has been made at this time, and the board continues to evaluate all
available options in light of the Company’s strategic and financial
priorities.
Should the board of directors resolve to proceed with
the Delisting from the CSE, a further announcement will be made by way
of news release in accordance with applicable regulatory
requirements.
Approval of Other Matters
The resolution to transact such other business as may
properly come before the Meeting, or any adjournment or postponement
thereof. The voting results are set out below:
Votes For | 3,521,762 | |
Votes Against | 73.02% | |
1,301,422 | ||
26.98% | ||
About Orion Nutraceuticals
Inc.
Orion Nutraceuticals Inc. is actively evaluating
potential investment and acquisition opportunities. Orion shares trade
in Canada on the CSE under the symbol ORI.
ON BEHALF OF THE BOARD
Guy Bourgeois, Director
Tel: (604) 687-2038
The CSE has
neither approved nor disapproved the contents of this news release.
Neither the CSE nor its Market Regulator (as that term is defined in
the policies of the CSE) accepts responsibility for the adequacy or
accuracy of this news release.
Forward-Looking
Statements
This news release contains
"forward-looking information" and "forward-looking
statements" (collectively, “forward-looking statements”)
within the meaning of applicable securities laws, including statements
regarding the Company’s intention to delist from CSE, the
anticipated benefits of the Delisting, the Company’s ongoing
obligations as a reporting issuer, and the potential impact on
shareholders and trading liquidity. Forward-looking statements are
based on the opinions, assumptions and estimates of management as of
the date they are made and are subject to various known and unknown
risks and uncertainties.
These risks include, but are not
limited to, changes in market conditions, regulatory developments, the
Company’s ability to maintain compliance with applicable laws, and
other factors that may cause actual outcomes to differ materially from
those expressed or implied by such forward-looking statements.
Readers are cautioned not to place
undue reliance on forward-looking statements. Except as required by
applicable law, the Company undertakes no obligation to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise.
Copyright (c) 2025 TheNewswire - All rights reserved.
